Stock vs Stock Comparison

argenx SE vs Agilent Technologies, Inc.

ARGX wins the Tale of the Tape 6–2.

ARGX$813.14
A$137.40

🏆 Tale of the Tape

62
ARGXA
31.1%Profitability (Net Margin)18.8%
37.1xValuation (P/E)27.3x
13.8%Efficiency (ROIC)11.8%
5/9Health (Piotroski F)5/9
23.7Safety (Altman Z)4.6
89.6%Growth (Rev YoY)6.7%
1.13Risk (Sharpe 1Y)0.32
0.19xBalance Sheet (D/E)0.89x
1.23%FCF Yield3.41%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.186
252-Day Correlation
0.193
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricARGXA
Market Cap$52.2B$38.2B
P/E Ratio37.1x27.3x
Forward P/E22.7x20.5x
P/B176.61x5.37x
Dividend Yield0.75%
Beta-0.061.22

Quantitative Metrics

MetricARGXA
DCF Fair Value$264.40$50.34
DCF Upside-67.3%-57.1%
Piotroski F5/95/9
Altman Z23.754.57
Beneish M-1.49-2.46
FCF Yield1.23%3.41%
Net Debt/EBITDA-2.6x0.7x
ROIC13.8%11.8%
WACC8.0%12.1%
ROIC – WACC5.8pp-0.3pp
Gross Margin89.1%52.4%
Net Margin31.1%18.8%
Rev Growth YoY89.6%6.7%
Sharpe (1Y)1.130.32
Max Drawdown 3Y-38.2%
FCF Payout Ratio24%

ARGX Price

Loading chart...

A Price

Loading chart...

ETF Exposure

ARGX found in:

IBB3.32%
VGK0.31%
SPDW0.15%
VSGX0.15%
VEA0.15%
CWI0.12%
VEU0.12%
VXUS0.11%
VT0.04%

A found in:

MOAT1.31%
VOT0.77%
XLV0.61%
VHT0.53%
VO0.33%
ONEV0.29%
RSP0.18%
VIG0.15%
VTV0.13%
SCHV0.12%
SPYV0.11%
IWD0.11%
VONV0.10%
ONEO0.09%
ESGV0.07%
QUS0.07%
SPLG0.07%
IVV0.07%
ITOT0.06%
SCHX0.06%
SCHB0.05%
SPY0.05%
VTI0.05%
VOO0.05%
VONE0.05%
SPTM0.05%
URTH0.04%
ACWI0.04%
DGRW0.04%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

ARGX vs A: Head-to-Head Analysis

argenx SE (ARGX) and Agilent Technologies, Inc. (A) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, ARGX leads 6–2 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, ARGX generates a return on invested capital (ROIC) of 13.8% compared to A's 11.8%. This suggests ARGX is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between ARGX and A is 0.186, indicating low correlation, making them an effective diversification pair in a portfolio context.

ARGX appears in 9 ETFs tracked by SecuritiesDB, while A appears in 29 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, ARGX or A?

Our quantitative analysis compares ARGX and A across nine fundamental dimensions. ARGX wins the Tale of the Tape 6–2. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are ARGX and A correlated?

The 252-day correlation between ARGX and A is 0.186. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.